Delivery Order SPE2DB22D1017-SPE2DB25FG5MA
Award Date 6/20/25
Potential Completion Date 6/23/25
Potential Value $9.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $8,143.08 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (7-count packages) on September 24, 2025, with an ultimate completion date of September 25, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Orilissa 150mg tablets (28-count packages) under a firm fixed-price contract valued at $10,105.73. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 3, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,491.20 delivery order to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (7-count package) under a firm fixed price contract type. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive delivery order supporting the federal government's pharmaceutical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $1,205.70 to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7) on April 29, 2025, with completion scheduled for April 30, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Orilissa is a prescription medication used in women's healthcare, reflecting the broad...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (7-count package) valued at $2,380.95 under a firm fixed-price contract. The award was made on December 16, 2025, with an ultimate completion date of December 17, 2025. This is a non-set-aside, competitively awarded delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a $6,382.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orilissa 150 mg tablets (quantity of 7 units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made to AmerisourceBergen's corporate office, with performance occurring at the company's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Orilissa 200 mg tablets in quantities of 14 units. This competitively awarded, non-set-aside contract carries a ceiling value of $10,756.65 and employs firm fixed price terms, with an ultimate completion date of December 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orilissa 200 mg tablets (14-count packaging) with a ceiling value of $8,559.49 under a firm fixed-price contract. This non-set-aside award was competitively procured and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Orilissa 150 mg tablets (seven-count packages) under a firm fixed-price contract valued at $4,756.11, with completion scheduled for September 8, 2025. This non-set-aside competitive award represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets in quantities of 7 units, valued at $8,696.28. This firm fixed-price delivery order, which was not set-aside, was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...